Back to Search
GEOFFREY SIMON, M.D.
M.D.
Pediatrics Physician
NPI: 1558366427Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
041485(GA)C10010179(DE)MD458449(PA)
Research & Publications (20)
Comparative assessment of large-scale proteomic studies of apoptotic proteolysis.
PMID 19415908·ACS Chem Biol·2009
4-observational
Amino acid precursors for the detection of transketolase activity in Escherichia coli auxotrophs.
PMID 19535247·Bioorg Med Chem Lett·2009
8-other
Sequential Cyk-4 binding to ECT2 and FIP3 regulates cleavage furrow ingression and abscission during cytokinesis.
PMID 18511905·EMBO J·2008
8-other
Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain.
PMID 18227059·J Biol Chem·2008
7-preclinical
Individualizing chemotherapy for non-small cell lung cancer (NSCLC) in the adjuvant and advanced setting: current status and future directions.
PMID 19266288·Curr Treat Options Oncol·2008
6-review
Mechanisms regulating targeting of recycling endosomes to the cleavage furrow during cytokinesis.
PMID 18481966·Biochem Soc Trans·2008
7-preclinical
Setting the stage for tailored chemotherapy in the management of non-small cell lung cancer.
PMID 18241000·Future Oncol·2008
6-review
Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial.
PMID 18640937·J Clin Oncol·2008
3-trial
Murine antithymocyte globulin therapy alters disease progression in NOD mice by a time-dependent induction of immunoregulation.
PMID 18039815·Diabetes·2008
7-preclinical
Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or older.
PMID 18300255·Cancer·2008
3-trial
Nuclear excision repair-based personalized therapy for non-small cell lung cancer: from hypothesis to reality.
PMID 17600754·Int J Biochem Cell Biol·2007
6-review
Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer.
PMID 17602079·J Clin Oncol·2007
3-trial
N170 ERPs could represent a logographic processing strategy in visual word recognition.
PMID 17451598·Behav Brain Funct·2007
8-other
Cost-effectiveness of systematic depression treatment among people with diabetes mellitus.
PMID 17199056·Arch Gen Psychiatry·2007
4-observational
Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
PMID 17873178·Chest·2007
6-review
Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway.
PMID 16818490·J Biol Chem·2006
7-preclinical
Orthographic transparency and grapheme-phoneme conversion: An ERP study in Arabic and French readers.
PMID 16822485·Brain Res·2006
4-observational
Increased bioavailability of intravenous versus oral CI-1033, a pan erbB tyrosine kinase inhibitor: results of a phase I pharmacokinetic study.
PMID 16899614·Clin Cancer Res·2006
3-trial
Sequential oral 9-nitrocamptothecin and etoposide: a pharmacodynamic- and pharmacokinetic-based phase I trial.
PMID 16928835·Mol Cancer Ther·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 795 E MARSHALL ST, SUITE 301-307
WEST CHESTER, PA 19380 - Phone
- (610) 429-1100
Quick Facts
- NPI
- 1558366427
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile